Supernus Pharmaceuticals
Biopharmaceutical company developing and commercializing CNS disease treatments.
About
Supernus Pharmaceuticals is an award-winning biopharmaceutical company with over 30 years of experience in developing and commercializing products to treat central nervous system (CNS) diseases. They offer novel products designed to provide important health benefits to patients living with CNS diseases and are actively engaged in research and development of promising product candidates. Teams look it up for Biotechnology, Pharmaceuticals, Healthcare.
Frequently asked
What does Supernus Pharmaceuticals do?
Supernus Pharmaceuticals is a Biotechnology company that offers Services. Teams look it up for Pharmaceuticals, Healthcare, Neuroscience. It is based in Rockville, United States and was founded in 2005. Public records show about 809 people and $18M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Supernus Pharmaceuticals raised?
Supernus Pharmaceuticals has raised a total of $18M in funding. The most recent round on record is Series A.
Where is Supernus Pharmaceuticals headquartered?
Supernus Pharmaceuticals is headquartered in Rockville, United States.
When was Supernus Pharmaceuticals founded?
Supernus Pharmaceuticals was founded in 2005.
What industry does Supernus Pharmaceuticals operate in?
Supernus Pharmaceuticals operates in Biotechnology, Pharmaceuticals, Healthcare, Neuroscience.
How many employees does Supernus Pharmaceuticals have?
Supernus Pharmaceuticals has approximately 809 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.